The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 15, 2015
Filed:
Jun. 18, 2013
Applicant:
Wellstat Therapeutics Corporation, Gaithersburg, MD (US);
Inventor:
Shalini Sharma, Gaithersberg, MD (US);
Assignee:
Wellstat Therapeutics Corporation, Gaithersburg, MD (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 37/10 (2006.01); C07B 41/12 (2006.01); A61K 31/165 (2006.01); A61K 31/192 (2006.01); A61K 31/216 (2006.01); A61K 31/235 (2006.01); A61K 31/41 (2006.01); A61K 31/4196 (2006.01); A61K 31/44 (2006.01); A61K 31/445 (2006.01); A61K 31/535 (2006.01); A61K 31/54 (2006.01); C07C 59/68 (2006.01); C07C 59/90 (2006.01); C07C 69/738 (2006.01); C07C 217/22 (2006.01); C07C 233/31 (2006.01); C07C 233/47 (2006.01); C07C 235/78 (2006.01); C07C 235/84 (2006.01); C07C 259/06 (2006.01); C07C 323/52 (2006.01); C07C 323/59 (2006.01); C07D 213/30 (2006.01); C07D 249/10 (2006.01); C07D 249/12 (2006.01); C07D 257/04 (2006.01); C07D 333/16 (2006.01); C07C 67/47 (2006.01); C07C 209/68 (2006.01); C07D 213/55 (2006.01); C07D 333/24 (2006.01);
U.S. Cl.
CPC ...
C07B 41/12 (2013.01); A01N 37/10 (2013.01); A61K 31/165 (2013.01); A61K 31/192 (2013.01); A61K 31/216 (2013.01); A61K 31/235 (2013.01); A61K 31/41 (2013.01); A61K 31/4196 (2013.01); A61K 31/44 (2013.01); A61K 31/445 (2013.01); A61K 31/535 (2013.01); A61K 31/54 (2013.01); C07C 59/68 (2013.01); C07C 59/90 (2013.01); C07C 67/47 (2013.01); C07C 69/738 (2013.01); C07C 209/68 (2013.01); C07C 217/22 (2013.01); C07C 233/31 (2013.01); C07C 233/47 (2013.01); C07C 235/78 (2013.01); C07C 235/84 (2013.01); C07C 259/06 (2013.01); C07C 323/52 (2013.01); C07C 323/59 (2013.01); C07D 213/30 (2013.01); C07D 213/55 (2013.01); C07D 249/10 (2013.01); C07D 249/12 (2013.01); C07D 257/04 (2013.01); C07D 333/16 (2013.01); C07D 333/24 (2013.01); C07C 2101/02 (2013.01); C07C 2102/04 (2013.01); Y10S 514/866 (2013.01);
Abstract
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.